tiprankstipranks
Stryker Corporation (SYK)
NYSE:SYK
US Market
Want to see SYK full AI Analyst Report?

Stryker (SYK) Earnings Dates, Call Summary & Reports

2,643 Followers

Earnings Data

Report Date
Jul 30, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
3.48
Last Year’s EPS
3.13
Same Quarter Last Year
Based on 23 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Apr 30, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call mixed a significant near-term operational setback—the late-quarter cyber incident that materially distorted Q1 results, pressured margins and reduced EPS—with several strong positives: rapid operational recovery, record Mako installations and robust robotic momentum, continued healthy underlying demand, strategic reorganization (Ortho Tech), active M&A (AVS) and maintained full-year guidance (organic sales growth 8.0%–9.5%, adjusted EPS $14.90–$15.10). Management expects most lost Q1 sales to be realized through the rest of the year, with catch-up skewed to the back half, and emphasized customer/employee support and successful recovery efforts.
Company Guidance
Stryker reiterated full‑year guidance despite the late‑quarter cyber incident, forecasting organic net sales growth of 8.0%–9.5% and full‑year adjusted net earnings per share of $14.90–$15.10, with adjusted other income and expense expected to be about $420 million and a full‑year effective tax rate of 15%–16%; management said most first‑quarter disruption will be recovered through the year with some revenue catch‑up in Q2 and more in H2, and that pricing should be modestly positive (with a slightly favorable FX/interest rate tailwind if rates hold and some anticipated tariff improvement). For Q1 they reported 2.4% organic sales growth (U.S. 1.9%, international 3.9%), pricing +0.3%, FX +1.6%, adjusted EPS of $2.60 (down $0.24 or 8.5% YoY), adjusted gross margin 63.6% (‑190 bps) and adjusted operating margin 21.1% (‑180 bps); YTD cash from operations was $581 million, gross debt/EBITDA was ~2.1x, and management continues to target healthy margin and cash conversion (roughly 70%–80% FCF conversion).
Organic Sales Growth Despite Disruption
Q1 organic net sales growth of 2.4% worldwide, with 1.9% growth in the U.S. and 3.9% internationally. Management emphasized underlying demand remained healthy across businesses despite the cyber incident.
Full-Year Guidance Reaffirmed
Company maintained full-year 2026 guidance: expected organic net sales growth of 8.0%–9.5% and adjusted net EPS of $14.90–$15.10, reflecting confidence that most lost Q1 sales will be realized over the remainder of the year.
Rapid Operational Recovery from Cyber Incident
As of the week of April 1, global manufacturing network was fully operational. Management reported successful removal of unauthorized party, restoration from backups, and prioritized patient care during recovery.
Record Mako Installations and Strong Robotic Momentum
Delivered best-ever Q1 for Mako installations in the U.S. and internationally with rising utilization rates. Mako Shoulder feedback positive and full launch on Mako 4 expected mid-year. New RPS handheld receiving strong early customer feedback.
Strategic Reorganization and Product Integration
Established new Ortho Tech business by combining Mako and Enabling Technologies with Orthopaedic Instruments to simplify customer experience, accelerate innovation and speed to market; segment disclosures updated accordingly.
M&A Activity and Pipeline
Announced agreement to acquire Amplitude Vascular Systems (expected to close in Q2) to expand peripheral vascular/cardiovascular offerings; management signaled active M&A pipeline and capacity to deploy capital (gross debt/EBITDA ~2.1x at quarter end).
Key Product Approvals and International Rollouts
Pangea received approval in Europe (and Japan earlier), LIFEPAK approvals in Europe; management expects Pangea and LIFEPAK to drive above-market growth internationally as production ramps.
Financial and Tax Positioning
Q1 adjusted effective tax rate was 14.5%; full-year 2026 effective tax rate expected 15%–16%. YTD cash from operations of $581M; company expects free cash flow conversion in the ~70%–80% range and maintained adjusted other income & expense full-year expectation of ~$420M.
Smart Hospital Launch
Launched Smart Hospital by combining Vocera and care.ai into SmartCare unit to provide integrated solutions (positive early customer feedback reported).

Stryker (SYK) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SYK Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 2026
2026 (Q2)
3.48 / -
3.13
Apr 30, 2026
2026 (Q1)
2.98 / 2.60
2.84-8.45% (-0.24)
Jan 29, 2026
2025 (Q4)
4.40 / 4.47
4.0111.47% (+0.46)
Oct 30, 2025
2025 (Q3)
3.13 / 3.19
2.8711.15% (+0.32)
Jul 31, 2025
2025 (Q2)
3.07 / 3.13
2.8111.39% (+0.32)
May 01, 2025
2025 (Q1)
2.71 / 2.84
2.513.60% (+0.34)
Jan 28, 2025
2024 (Q4)
3.87 / 4.01
3.4615.90% (+0.55)
Oct 29, 2024
2024 (Q3)
2.77 / 2.87
2.4616.67% (+0.41)
Jul 30, 2024
2024 (Q2)
2.79 / 2.81
2.5410.63% (+0.27)
Apr 30, 2024
2024 (Q1)
2.36 / 2.50
2.1416.82% (+0.36)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SYK Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 30, 2026
$315.13$294.73-6.47%
Jan 29, 2026
$353.34$368.56+4.31%
Oct 30, 2025
$367.07$354.39-3.45%
Jul 31, 2025
$389.81$374.98-3.80%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Stryker Corporation (SYK) report earnings?
Stryker Corporation (SYK) is schdueled to report earning on Jul 30, 2026, After Close (Confirmed).
    What is Stryker Corporation (SYK) earnings time?
    Stryker Corporation (SYK) earnings time is at Jul 30, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SYK EPS forecast?
          SYK EPS forecast for the fiscal quarter 2026 (Q2) is 3.48.